Divi's Laboratories Limited (DIVISLAB)
ISIN: - Industry: Drug Manufacturers—Specialty & Generic Sector: Healthcare Website
3404.7
32.0(0.95%)

Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, the United States, Asia, Europe, and internationally. It also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids, as well as markets vitamins to nutritional, pharma, food/beverage, and feed industries. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.

Pricing Updates

TODAY'S HIGH

3420

TODAY'S LOW

3346.35

52 WEEK HIGH

4977.8

52 WEEK LOW

3195.15

Major Holders

% of Shares Held by
All Insider

52.37%

% of Shares Held by
Institutions

27.58%

% of Float Held by
Institutions

57.91%

Number of Institutions
Holding Shares

210

Company Overview

MARKET CAP

90384.22 Cr.

ETERPRISE VALUE

87439 Cr.

NO. OF SHARES

26.54 Cr.

BOOK VALUE

450.871

DIV. YIELD

30%

DEBT

3.30 Cr.

GROSS PROFIT

5799.45 Cr.

CASH

3336.63 Cr.

REVENUE

9120.83 Cr.

REVENUE/SHARE

341.867

OHLC Chart 1y 2y 5y 10y

Price Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Volumes Chart

1d 1w 1m 3m 6m 1Yr 2Yr 5Yr

Cashflows

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Investments-1548.53 Cr.928.16 Cr.1056.29 Cr.-42.95 Cr.
Change To Liabilities34.27 Cr.174.80 Cr.93.85 Cr.84.16 Cr.
Total cashflows from Investing Activities-2194.92 Cr.75.13 Cr.-83.47 Cr.-685.40 Cr.
Net Borrowings-1.14 Cr.-34.02 Cr.-61.20 Cr.77.60 Cr.
Total Cash from Financing Activities-532.44 Cr.-34.89 Cr.-1091.42 Cr.-245.94 Cr.
Other Liabilities20.29 Cr.107.89 Cr.-13.93 Cr.23.15 Cr.
Total Assets0000
Net Income2960.45 Cr.1984.29 Cr.1376.54 Cr.1352.74 Cr.
Change in Cash-815.56 Cr.1987.17 Cr.41.05 Cr.22.96 Cr.
Effect of Exchange Rate0000
Total Cash from Operating Activities1911.80 Cr.1946.93 Cr.1215.94 Cr.954.30 Cr.
Depreciation311.51 Cr.252.62 Cr.183.38 Cr.166.24 Cr.
Other Cashflows from Investing Activities66.81 Cr.57.01 Cr.43.09 Cr.90.60 Cr.
Dividends Paid-530.94 Cr.-530.94 Cr.-849.50 Cr.-265.47 Cr.
Change to Inventory-683.39 Cr.-281.37 Cr.-91.52 Cr.-421.67 Cr.
Change to Account Receivables-741.62 Cr.-265.40 Cr.-206.70 Cr.-185.48 Cr.
Other Cashflows from Financing Activities-36 Lakhs-87 Lakhs-180.72 Cr.-58.07 Cr.
Change to Net Income10.29 Cr.-28.87 Cr.-128.54 Cr.-67.50 Cr.
Capital Expenditures-713.20 Cr.-910.19 Cr.-1183.21 Cr.-733.07 Cr.

Financials

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Research DevelopmentNoneNoneNoneNone
Effect of Accounting ChargesNoneNoneNoneNone
Income Before Tax3683.50 Cr.2666.04 Cr.1819.46 Cr.1855.07 Cr.
Minority InterestNoneNoneNoneNone
Net Income3570.43 Cr.2614.76 Cr.1639.23 Cr.1708.63 Cr.
Selling General Administrative946.16 Cr.836.69 Cr.631.68 Cr.551.90 Cr.
Gross Profit5992.69 Cr.4497.65 Cr.3148.92 Cr.3022.19 Cr.
Ebit3570.43 Cr.2614.76 Cr.1639.23 Cr.1708.63 Cr.
Operating Income3570.43 Cr.2614.76 Cr.1639.23 Cr.1708.63 Cr.
Other Operating Expenses1164.59 Cr.790.61 Cr.691.77 Cr.592.14 Cr.
Interest Expense-80 Lakhs-39 Lakhs-5.54 Cr.-2.12 Cr.
Extraordinary ItemsNoneNoneNoneNone
Non RecurringNoneNoneNoneNone
Other ItemsNoneNoneNoneNone
Income Tax Expense723.05 Cr.681.75 Cr.442.92 Cr.502.33 Cr.
Total Revenue8959.83 Cr.6969.47 Cr.5394.47 Cr.4946.27 Cr.
Total Operating Expenses5389.40 Cr.4354.71 Cr.3755.24 Cr.3237.64 Cr.
Cost of Revenue2967.14 Cr.2471.82 Cr.2245.55 Cr.1924.08 Cr.
Total Other Income Expense Net113.07 Cr.51.28 Cr.180.23 Cr.146.44 Cr.
Discontinued OperationsNoneNoneNoneNone
Net Income from Continuous Ops.2960.45 Cr.1984.29 Cr.1376.54 Cr.1352.74 Cr.
Net Income Applicable to Common Shares2960.45 Cr.1984.29 Cr.1376.54 Cr.1352.74 Cr.

Balance Sheet

ParticularsMar 2022Mar 2021Mar 2020Mar 2019
Intangible Assets7.49 Cr.4.95 Cr.3.60 Cr.4.05 Cr.
Capital Surplus079.88 Cr.79.88 Cr.79.88 Cr.
Total Liabilities1646.53 Cr.1479.46 Cr.1225.78 Cr.1081.10 Cr.
Stock Holder Equity11728.18 Cr.9294.61 Cr.7309.92 Cr.6957.15 Cr.
Minority Interest0000
Other Liabilities394.88 Cr.99.55 Cr.112.82 Cr.74.32 Cr.
Total Assets13374.71 Cr.10774.07 Cr.8535.70 Cr.8038.25 Cr.
Common Stock53.09 Cr.53.09 Cr.53.09 Cr.53.09 Cr.
Retained Earnings09148.01 Cr.7163.56 Cr.6816.35 Cr.
Other Liabilities448.11 Cr.363.31 Cr.294.48 Cr.234.35 Cr.
Good Will0000
Treasury Stock11675.09 Cr.13.63 Cr.13.39 Cr.7.83 Cr.
Other Assets156.22 Cr.184.86 Cr.154.32 Cr.261.26 Cr.
Cash2818.88 Cr.2030.32 Cr.43.15 Cr.13 Cr.
Current Liabilities1195.55 Cr.1112.46 Cr.926.83 Cr.846.75 Cr.
Long Term Asset Charges14.47 Cr.3.23 Cr.4.38 Cr.2.34 Cr.
Short Long Term Debt0000
Other Stockholder Equity11675.09 Cr.13.63 Cr.13.39 Cr.7.83 Cr.
Property Plant Equipment4787.49 Cr.4409.54 Cr.3697.94 Cr.2575.63 Cr.
Total Cur. Assets8351.50 Cr.6174.71 Cr.4679.83 Cr.4650.05 Cr.
Long Term Investments72.01 Cr.1 Lakh1 Lakh547.26 Cr.
Net Tangible Assets11720.69 Cr.9289.66 Cr.7306.32 Cr.6953.10 Cr.
Short Term Investments054.64 Cr.11.01 Cr.0
Net Receivables2423.88 Cr.1778.30 Cr.1599.04 Cr.1296.49 Cr.
Long Term Debt0000
Inventory2828.62 Cr.2145.23 Cr.1863.86 Cr.1772.34 Cr.
Accounts Payable795.70 Cr.763.20 Cr.590.72 Cr.492.26 Cr.

New Offers


Upstox offer
Upstox

Open a demat account through us and get the account opening charges waived off

open paperless account